Relative risk reduction is a troublesome way to convey the benefits of treatments
How excited would you be about a medication that lowered your risk of cardiovascular death, heart attack or stroke by 1.5%? Excited enough to spend a few thousand dollars a year on the drug? I expect not.
What if, instead, the drug reduced those same terrible outcomes by 20%? That’s probably enough benefit to interest some in the drug.
Well, those statistics come from the same clinical trial, evaluating the same drug. …
Relative risk reduction is a troublesome way to convey the benefits of treatments




![Proactive monitoring can prevent emergencies by catching heart signals early [PODCAST]](https://kevinmd.com/wp-content/uploads/unnamed-65-190x100.jpg)






![Politics and fear have replaced science in U.S. pain management [PODCAST]](https://kevinmd.com/wp-content/uploads/11c2db8f-2b20-4a4d-81cc-083ae0f47d6e-190x100.jpeg)






